Altered mitochondrial functionality in metabolic disorders: insights from Drosophila studies

Area of Science:

• Metabolic disorders
• Mitochondrial biology
• Model organism research

Background:

• Obesity and type 2 diabetes (T2D) are linked to mitochondrial dysfunction.
• Impaired mitochondrial quality control exacerbates metabolic diseases.
• Current treatments for obesity and T2D are insufficient for sustained remission.

Purpose of the Study:

• To review advances in mitochondrial research for metabolic disorders.
• To highlight the utility of Drosophila melanogaster as a model organism.
• To explore how Drosophila models dissect mitochondrial function in metabolic disease.

Main Methods:

• Review of current literature on mitochondrial dysfunction in obesity and T2D.
• Analysis of Drosophila melanogaster as a model for metabolic research.
• Examination of Drosophila models for diet-induced metabolic phenotypes.

Main Results:

• Drosophila models successfully replicate diet-induced mitochondrial fragmentation, adipose expansion, and insulin resistance.
• Genetic manipulation in Drosophila provides insights into mitochondrial roles in metabolic dysfunction.
• Drosophila facilitates in vivo imaging and genetic studies of mitochondrial-metabolism interactions.

Conclusions:

• Drosophila melanogaster is a valuable in vivo model for studying mitochondrial function in metabolic disorders.
• Future research should integrate multi-omics and precision medicine for mitochondrial metabolic remodeling.
• Developing non-invasive interventions is crucial for advancing translational medicine in obesity and T2D.